Search for: "George v. Lowe's Cos., Inc" Results 21 - 40 of 72
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Jul 2017, 10:21 am by Schachtman
The readers in his study found a very low level of positive films (less than 5%), despite their having been interpreted as showing pneumoconiosis by the litigation physicians. [read post]
29 Nov 2016, 2:44 am
In Interflora Inc v Marks and Spencer Plc [2012] EWCA Civ 1501 Lewison LJ referred to Neutrogena [1996] R.P.C. 473 that:"...There is passing off even if most of the people are not fooled most of the time but enough are for enough of the time. [read post]
28 Nov 2016, 4:02 pm by Amanda Pickens
Lowe’s Co., Inc., et. al., No. 5:16-cv-00161 (W.D.N.C. [read post]
30 Sep 2016, 7:58 am by Amanda Pickens
Lowe’s Co., Inc., et. al., No. 5:16-cv-00161 (W.D.N.C. [read post]
28 Jun 2016, 2:37 pm by Howard Knopf
The really important numbers, using the Board’s own taxonomy, as seen below, are quite probably much too low to be susceptible to statistical analysis. [read post]
18 May 2016, 1:00 pm by Doorey
 Where PCC interns are performing work that primarily benefits their placement organization or where they are performing work that would otherwise be done by employees, there is a good chance these internships would not meet the test under s. 1(2):  see Girex Bancorp Inc. v. [read post]
17 May 2016, 9:01 pm by Michael C. Dorf
Monday’s Supreme Court ruling in Spokeo, Inc. v. [read post]
25 Apr 2015, 11:03 am by Schachtman
By adopting a more nuanced analysis, the Second Edition deprived defense counsel of a readily citable source for the proposition that low relative risks do not support inferences of specific causation. [read post]
9 Oct 2014, 9:12 am
If, however, the injured person paid less than the exchange rate, he can recover no more than the amount paid, except when the low rate was intended as a gift to him.Id. [read post]
4 Nov 2013, 9:46 am by Jane Chong
Over the last month, on our New Republic: Security States newsfeed, we rolled out a series designed to explain why fairly allocating the costs of software deficiencies between software makers and users is so critical to addressing the growing problem of vulnerability-ridden code—and how such a regime will require questioning some of our deep-seated beliefs about the very nature of software security. [read post]
5 Jun 2013, 5:29 am by Schachtman
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]